Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
2.900
+0.110 (3.94%)
Dec 20, 2024, 4:00 PM EST - Market closed
Prime Medicine Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | 0.8 | - | - | - | 5.21 | - |
| Cost of Revenue | 162.64 | 147.91 | 86.73 | 70.55 | 2.98 | 2.76 |
| Gross Profit | -161.84 | -147.91 | -86.73 | -70.55 | 2.23 | -2.76 |
| Selling, General & Admin | 50.94 | 43.39 | 29.82 | 13.92 | 3.16 | 3.76 |
| Operating Expenses | 50.94 | 43.39 | 29.82 | 13.92 | 3.16 | 3.76 |
| Operating Income | -212.79 | -191.29 | -116.54 | -84.47 | -0.93 | -6.52 |
| Other Non Operating Income (Expenses) | 8.63 | 8.76 | 1.9 | -80.99 | -11.48 | -1.06 |
| EBT Excluding Unusual Items | -204.49 | -182.53 | -114.64 | -165.46 | -12.41 | -7.58 |
| Gain (Loss) on Sale of Investments | -1.26 | -2.38 | -8.13 | -0.39 | 10.87 | - |
| Other Unusual Items | -13.5 | -13.5 | - | - | - | - |
| Pretax Income | -219.25 | -198.41 | -122.77 | -165.85 | -1.54 | -7.58 |
| Income Tax Expense | - | -0.28 | -0.95 | -0.49 | 1.87 | 0.01 |
| Net Income | -219.25 | -198.13 | -121.82 | -165.37 | -3.41 | -7.59 |
| Preferred Dividends & Other Adjustments | - | - | 20.19 | 18.75 | 1.65 | 0.8 |
| Net Income to Common | -219.25 | -198.13 | -142.01 | -184.12 | -5.06 | -8.38 |
| Shares Outstanding (Basic) | 109 | 91 | 34 | 13 | 3 | 1 |
| Shares Outstanding (Diluted) | 109 | 91 | 34 | 13 | 3 | 1 |
| Shares Change (YoY) | 26.37% | 168.42% | 161.23% | 391.47% | 77.53% | - |
| EPS (Basic) | -2.01 | -2.18 | -4.19 | -14.19 | -1.91 | -5.64 |
| EPS (Diluted) | -2.01 | -2.18 | -4.19 | -14.19 | -1.91 | -5.64 |
| Free Cash Flow | -190.32 | -174.14 | -147.92 | -38.23 | -6.18 | -4 |
| Free Cash Flow Per Share | -1.75 | -1.91 | -4.36 | -2.95 | -2.34 | -2.69 |
| Gross Margin | - | - | - | - | 42.80% | - |
| Operating Margin | -26598.50% | - | - | - | -17.89% | - |
| Profit Margin | -27406.12% | - | - | - | -97.02% | - |
| Free Cash Flow Margin | -23789.63% | - | - | - | -118.68% | - |
| EBITDA | -207.13 | -186.64 | -114.32 | -83.91 | -0.89 | - |
| EBITDA Margin | - | - | - | - | -17.06% | - |
| D&A For EBITDA | 5.66 | 4.65 | 2.22 | 0.57 | 0.04 | - |
| EBIT | -212.79 | -191.29 | -116.54 | -84.47 | -0.93 | -6.52 |
| EBIT Margin | - | - | - | - | -17.89% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.